Inogen Inc INGN
Analyst Ratings
- Consensus
- Buy — 1 Buy · 0 Hold · 0 Sell (1 analysts)
- Avg. Price Target
- $12.00 (+134.4% upside)
Key Stats
- Today's Range
- $5.10 – $5.18
- 50-Day Range
- $5.05 – $6.93
- 52-Week Range
- $5.05 – $9.13
- Volume
- 126K shs
- Average Volume
- 268K shs
- Market Cap
- $136.14 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 0.78
- Price / Sales
- 0.38
Short Interest
- Short Interest
- 3.20%
- Days to Cover
- 9.08
Financials (TTM)
- Revenue
- $354.30 million
- Net Income
- $-24,595,000
- Net Margin
- -6.94%
- Return on Equity
- -14.07%
- Debt-to-Equity
- —
About Inogen Inc
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
Related Stocks
Compare head-to-head: INGN vs STE·INGN vs ZBH·INGN vs MSA·INGN vs SMTI
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.